289 related articles for article (PubMed ID: 32143686)
41. Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.
Jayappa KD; Ao Z; Wang X; Mouland AJ; Shekhar S; Yang X; Yao X
J Virol; 2015 Apr; 89(7):3497-511. PubMed ID: 25568209
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 uncoats in the nucleus near sites of integration.
Burdick RC; Li C; Munshi M; Rawson JMO; Nagashima K; Hu WS; Pathak VK
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5486-5493. PubMed ID: 32094182
[TBL] [Abstract][Full Text] [Related]
43. The effect of capsid mutations on HIV-1 uncoating.
Wacharapornin P; Lauhakirti D; Auewarakul P
Virology; 2007 Feb; 358(1):48-54. PubMed ID: 16996553
[TBL] [Abstract][Full Text] [Related]
44. Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α.
Battivelli E; Lecossier D; Clavel F; Hance AJ
PLoS One; 2013; 8(1):e52434. PubMed ID: 23320071
[TBL] [Abstract][Full Text] [Related]
45. Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.
Desai TM; Marin M; Sood C; Shi J; Nawaz F; Aiken C; Melikyan GB
Retrovirology; 2015 Oct; 12():88. PubMed ID: 26511606
[TBL] [Abstract][Full Text] [Related]
46. Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis.
Márquez CL; Lau D; Walsh J; Shah V; McGuinness C; Wong A; Aggarwal A; Parker MW; Jacques DA; Turville S; Böcking T
Elife; 2018 Jun; 7():. PubMed ID: 29877795
[TBL] [Abstract][Full Text] [Related]
47. Roles of HIV-1 capsid in viral replication and immune evasion.
Le Sage V; Mouland AJ; Valiente-Echeverría F
Virus Res; 2014 Nov; 193():116-29. PubMed ID: 25036886
[TBL] [Abstract][Full Text] [Related]
48. Nuclear Capsid Uncoating and Reverse Transcription of HIV-1.
Müller TG; Zila V; Müller B; Kräusslich HG
Annu Rev Virol; 2022 Sep; 9(1):261-284. PubMed ID: 35704745
[TBL] [Abstract][Full Text] [Related]
49. Gene expression analysis of a panel of cell lines that differentially restrict HIV-1 CA mutants infection in a cyclophilin a-dependent manner.
Shah VB; Aiken C
PLoS One; 2014; 9(3):e92724. PubMed ID: 24663101
[TBL] [Abstract][Full Text] [Related]
50. Fluorescent image analysis of HIV-1 and HIV-2 uncoating kinetics in the presence of old world monkey TRIM5α.
Takeda E; Kono K; Hulme AE; Hope TJ; Nakayama EE; Shioda T
PLoS One; 2015; 10(3):e0121199. PubMed ID: 25803716
[TBL] [Abstract][Full Text] [Related]
51. Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle.
Novikova M; Zhang Y; Freed EO; Peng K
Virol Sin; 2019 Apr; 34(2):119-134. PubMed ID: 31028522
[TBL] [Abstract][Full Text] [Related]
52. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.
De Iaco A; Luban J
Retrovirology; 2014 Jan; 11():11. PubMed ID: 24479545
[TBL] [Abstract][Full Text] [Related]
53. Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells.
Koh K; Miyaura M; Yoshida A; Sakurai A; Fujita M; Adachi A
Microbes Infect; 2000 Oct; 2(12):1419-23. PubMed ID: 11099927
[TBL] [Abstract][Full Text] [Related]
54. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
55. Disassembling the Nature of Capsid: Biochemical, Genetic, and Imaging Approaches to Assess HIV-1 Capsid Functions.
Ingram Z; Fischer DK; Ambrose Z
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835043
[TBL] [Abstract][Full Text] [Related]
56. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A.
Li Y; Kar AK; Sodroski J
J Virol; 2009 Nov; 83(21):10951-62. PubMed ID: 19656870
[TBL] [Abstract][Full Text] [Related]
57. The fate of HIV-1 capsid: a biochemical assay for HIV-1 uncoating.
Yang Y; Luban J; Diaz-Griffero F
Methods Mol Biol; 2014; 1087():29-36. PubMed ID: 24158811
[TBL] [Abstract][Full Text] [Related]
58. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.
Ambrose Z; Aiken C
Virology; 2014 Apr; 454-455():371-9. PubMed ID: 24559861
[TBL] [Abstract][Full Text] [Related]
59. HIV-1 uncoating requires long double-stranded reverse transcription products.
Burdick RC; Morse M; Rouzina I; Williams MC; Hu WS; Pathak VK
Sci Adv; 2024 Apr; 10(17):eadn7033. PubMed ID: 38657061
[TBL] [Abstract][Full Text] [Related]
60. In vitro uncoating of HIV-1 cores.
Shah VB; Aiken C
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22105356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
